Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Join SI Premium – FREE
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two stock drops as GTA 6 leaks continue
- Department of War adds Starshield AI's Grok to GenAI platform
- Lionel Messi says he will leave Argentine national team
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
